Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Oncology Institute (TOI) Accumulated Depreciation & Amortization: 2020-2025

Historic Accumulated Depreciation & Amortization for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Oncology Institute's Accumulated Depreciation & Amortization rose 953.59% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 953.59%. This contributed to the annual value of $6.3 million for FY2024, which is 704.92% up from last year.
  • As of Q3 2025, Oncology Institute's Accumulated Depreciation & Amortization stood at $1.7 million, which was up 953.59% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Oncology Institute's Accumulated Depreciation & Amortization peaked at $1.8 million during Q2 2025, and registered a low of $777000.0 during Q1 2021.
  • Over the past 5 years, Oncology Institute's median Accumulated Depreciation & Amortization value was $1.3 million (recorded in 2023), while the average stood at $1.3 million.
  • In the last 5 years, Oncology Institute's Accumulated Depreciation & Amortization soared by 31957.04% in 2021 and then tumbled by 736.16% in 2024.
  • Quarter analysis of 5 years shows Oncology Institute's Accumulated Depreciation & Amortization stood at $920000.0 in 2021, then grew by 29.57% to $1.2 million in 2022, then skyrocketed by 32.3% to $1.6 million in 2023, then increased by 8.24% to $1.7 million in 2024, then increased by 0.94% to $1.7 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $1.7 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.8 million for Q1 2025.